Monika Lamparska‐Przybysz
Monika Lamparska‐Przybysz publishes mostly in Molecular Biology, Oncology and Pathology and Forensic Medicine, on topics such as Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation and Cytokine Signaling Pathways and Interactions.
- World rank
- #4,575,783 of 7,710,434 ranked researchers
- Rank in Poland
- #36,100 of 100,960
- Works
- 35
- Citations
- 553
- Citations per work
- 15.8
What does Monika Lamparska‐Przybysz research?
Monika Lamparska‐Przybysz's work is mostly in Biochemistry, Genetics and Molecular Biology (41%), Medicine (23%), Chemistry (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1441.3%
- Everything else1131.6%
- Health Sciences822.8%
- Medicine822.8%
- Physical Sciences24.3%
- Chemistry24.3%
- 1Molecular Biology37% of their works
- 2Oncology12% of their works
- 3Pathology and Forensic Medicine5% of their works
- 4Genetics5% of their works
- 5Cancer Research4% of their works
- 6Organic Chemistry4% of their works
Research topics
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- Cytokine Signaling Pathways and Interactions
- RNA Interference and Gene Delivery
- Cell death mechanisms and regulation
- Fibroblast Growth Factor Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
Which keywords describe Monika Lamparska‐Przybysz's research?
The keywords of their largest research topics: Cancer, Development, Wnt Signaling, ß-Catenin, Arginine Methylation, Protein Arginine Methyltransferases, IL-6 and STAT3.
- siRNA Delivery
- Myelofibrosis
- Imatinib
- FGF21
- BCR-ABL
- STAT3
- Protein Arginine Methyltransferases
- ß-Catenin
- Development
- Cancer
- Wnt Signaling
- Arginine Methylation
- IL-6
- Apoptosis
- Cell Death
- Fibroblast Growth Factor
- JAK2 Mutation
- RNA Interference
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cancer214 topics
- Development102 topics
- Wnt Signaling71 topic
- ß-Catenin71 topic
- Arginine Methylation61 topic
- Protein Arginine Methyltransferases61 topic
- IL-651 topic
- STAT351 topic
- Apoptosis31 topic
- BCR-ABL31 topic
- Cell Death31 topic
- FGF2131 topic
- Fibroblast Growth Factor31 topic
- Imatinib31 topic
- JAK2 Mutation31 topic
- Myelofibrosis31 topic
- RNA Interference31 topic
- siRNA Delivery31 topic
Where does Monika Lamparska‐Przybysz work?
Monika Lamparska‐Przybysz's main affiliation in the publication record is Celon Pharma (Poland), Poland.
How many publications and citations does Monika Lamparska‐Przybysz have?
OpenAlex counts 35 works and 553 citations for Monika Lamparska‐Przybysz, an h-index of 10, ranking #4,575,783 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Monika Lamparska‐Przybysz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.